Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia.
Med J Aust. 2011 Jul 18;195(2):69-73. doi: 10.5694/j.1326-5377.2011.tb03209.x.
To determine the Australian native ant species associated with ant sting anaphylaxis, geographical distribution of allergic reactions, and feasibility of diagnostic venom-specific IgE (sIgE) testing.
DESIGN, SETTING AND PARTICIPANTS: Descriptive clinical, entomological and immunological study of Australians with a history of ant sting anaphylaxis, recruited in 2006-2007 through media exposure and referrals from allergy practices and emergency physicians nationwide. We interviewed participants, collected entomological specimens, prepared reference venom extracts, and conducted serum sIgE testing against ant venom panels relevant to the species found in each geographical region.
Reaction causation attributed using a combination of ant identification and sIgE testing.
376 participants reported 735 systemic reactions. Of 299 participants for whom a cause was determined, 265 (89%; 95% CI, 84%-92%) had reacted clinically to Myrmecia species and 34 (11%; 95% CI, 8%-16%) to green-head ant (Rhytidoponera metallica). Of those with reactions to Myrmecia species, 176 reacted to jack jumper ant (Myrmecia pilosula species complex), 18 to other jumper ants (15 to Myrmecia nigrocincta, three to Myrmecia ludlowi) and 56 to a variety of bulldog ants, with some participants reacting to more than one type of bulldog ant. Variable serological cross-reactivity between bulldog ant species was observed, and sera from patients with bulldog ant allergy were all positive to one or more venoms extracted from Myrmecia forficata, Myrmecia pyriformis and Myrmecia nigriceps.
Four main groups of Australian ants cause anaphylaxis. Serum sIgE testing enhances the accuracy of diagnosis and is a prerequisite for administering species-specific venom immunotherapy.
确定与蚂蚁蜇伤过敏反应相关的澳大利亚本土蚂蚁物种、过敏反应的地理分布以及诊断性毒液特异性 IgE(sIgE)检测的可行性。
设计、地点和参与者:对 2006-2007 年通过媒体曝光以及全国过敏症诊所和急诊医生转介招募的有蚂蚁蜇伤过敏反应史的澳大利亚人进行了描述性临床、昆虫学和免疫学研究。我们对参与者进行了访谈,收集了昆虫学标本,制备了参考毒液提取物,并针对在每个地理区域发现的物种进行了血清 sIgE 检测。
使用蚂蚁鉴定和 sIgE 检测相结合来确定反应的原因。
376 名参与者报告了 735 例全身性反应。在 299 名确定病因的参与者中,265 名(89%;95%CI,84%-92%)对 Myrmecia 物种有临床反应,34 名(11%;95%CI,8%-16%)对绿头蚁(Rhytidoponera metallica)有反应。在对 Myrmecia 物种有反应的参与者中,176 名对杰克跳蚁(Myrmecia pilosula 物种复合体)有反应,18 名对其他跳蚁(15 名对 Myrmecia nigrocincta,3 名对 Myrmecia ludlowi)有反应,56 名对各种斗牛犬蚁有反应,有些参与者对一种以上的斗牛犬蚁有反应。观察到斗牛犬蚁种间存在可变的血清交叉反应性,并且斗牛犬蚁过敏患者的血清均对从 Myrmecia forficata、Myrmecia pyriformis 和 Myrmecia nigriceps 中提取的一种或多种毒液呈阳性。
四种主要的澳大利亚蚂蚁会引起过敏反应。血清 sIgE 检测可提高诊断的准确性,是进行特异性毒液免疫治疗的前提。